China Foods Holdings Ltd.

CFOO ·Healthcare, Drug Manufacturers - General, Hong Kong
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $327.9K $233.3K $158.5K $354.1K $361.1K $1.0M $3.4M $0
Cost of Revenue $297.9K $179.5K $94.3K $243.0K $121.7K $596.5K $2.7M $0
Gross Profit $30.0K $53.9K $64.1K $111.1K $239.4K $416.6K $720.2K $0
Gross Margin 9.1% 23.1% 40.5% 31.4% 66.3% 41.1% 21.3%
Operating Expenses
Research & Development
SG&A Expense $423.6K $502.7K $465.2K $500.8K $690.8K $729.0K $490.9K $42.3K
Operating Income $-398.9K $-455.6K $-404.6K $-392.7K $-456.4K $-470.8K $88.5K $-42.3K
Operating Margin -121.7% -195.3% -255.3% -110.9% -126.4% -46.5% 2.6%
Interest Expense
Pretax Income $-398.7K $-454.7K $-403.7K $-353.3K $-448.7K $-461.3K $89.1K $-62.7K
Income Tax Expense $836 $828 $6.7K $8.2K $6.3K $100
Net Income $-398.7K $-455.6K $-403.7K $-354.1K $-455.4K $-469.5K $82.8K $-62.8K
Net Margin -121.6% -195.2% -254.7% -100.0% -126.1% -46.3% 2.4%
EPS (Basic) $-0.02 $-0.02 $-0.02 $-0.02 $-0.02 $-0.03 $0.01 $-0.01
EPS (Diluted) $-0.02 $-0.02 $-0.02 $-0.02 $-0.02 $-0.03 $0.01 $-0.01
Shares Outstanding (Basic) 20.3M 20.3M 20.3M 20.3M 20.3M 17.5M 15.0M 5.3M
Shares Outstanding (Diluted) 20.3M 20.3M 20.3M 20.3M 20.3M 17.5M 15.0M 5.3M
Dividends Per Share
← Newer Page 1 of 2 Older →